Skip to main content

Appropriate baseline laboratory testing following ACEI or ARB initiation by Medicare FFS beneficiaries.

Publication ,  Journal Article
Maciejewski, ML; Hammill, BG; Qualls, LG; Hastings, SN; Wang, V; Curtis, LH
Published in: Pharmacoepidemiol Drug Saf
September 2016

BACKGROUND: Laboratory testing to identify contraindications and adverse drug reactions is important for safety of patients initiating angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs). Rates and predictors of appropriate testing among Medicare fee-for-service beneficiaries are unknown. PURPOSE: The study's purpose was to examine baseline laboratory testing rates, identify predictors of suboptimal testing, and assess the prevalence of abnormal creatinine and potassium among beneficiaries initiating ACE inhibitors or ARBs. DESIGN AND SUBJECTS: Retrospective cohort of 101 376 fee-for-service beneficiaries from 10 eastern US states in 1 July to 30 November 2011. MAIN MEASURES: Appropriate monitoring for serum creatinine or serum potassium was defined as evidence of an outpatient claim within 180 days before or 14 days after the index prescription fill date. KEY RESULTS: Thirty-eight percent of beneficiaries were men, 78% were White race, 26% had prevalent heart failure, and 89% had prevalent hypertension. Rates of appropriate baseline laboratory testing were 82.7% for potassium, 83.2% for creatinine, and 82.6% for both potassium and creatinine 180 days prior to initiation. In logistic regression, men (odds ratio [OR] = 1.15, 95% confidence interval [CI]: 1.11, 1.19), African-Americans (OR = 1.26, 95%CI: 1.20, 1.32), and beneficiaries with Alzheimer's disease and related disorders (OR = 1.22, 95%CI: 1.15, 1.28) or stroke (OR = 1.34, 95%CI: 1.26, 1.43) were more likely to experience suboptimal testing. At baseline, hyperkalemia was relatively uncommon (5.8%), and elevated creatinine values were rare (1.4%). CONCLUSIONS: Appropriate monitoring could be improved for African-American beneficiaries and beneficiaries with a history of stroke or Alzheimer's disease and related disorders initiating ACE inhibitors or ARBs. Copyright © 2016 John Wiley & Sons, Ltd.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Pharmacoepidemiol Drug Saf

DOI

EISSN

1099-1557

Publication Date

September 2016

Volume

25

Issue

9

Start / End Page

1015 / 1022

Location

England

Related Subject Headings

  • White People
  • United States
  • Retrospective Studies
  • Potassium
  • Pharmacology & Pharmacy
  • Medicare
  • Male
  • Logistic Models
  • Hypertension
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Maciejewski, M. L., Hammill, B. G., Qualls, L. G., Hastings, S. N., Wang, V., & Curtis, L. H. (2016). Appropriate baseline laboratory testing following ACEI or ARB initiation by Medicare FFS beneficiaries. Pharmacoepidemiol Drug Saf, 25(9), 1015–1022. https://doi.org/10.1002/pds.3994
Maciejewski, Matthew L., Bradley G. Hammill, Laura G. Qualls, Susan N. Hastings, Virginia Wang, and Lesley H. Curtis. “Appropriate baseline laboratory testing following ACEI or ARB initiation by Medicare FFS beneficiaries.Pharmacoepidemiol Drug Saf 25, no. 9 (September 2016): 1015–22. https://doi.org/10.1002/pds.3994.
Maciejewski ML, Hammill BG, Qualls LG, Hastings SN, Wang V, Curtis LH. Appropriate baseline laboratory testing following ACEI or ARB initiation by Medicare FFS beneficiaries. Pharmacoepidemiol Drug Saf. 2016 Sep;25(9):1015–22.
Maciejewski, Matthew L., et al. “Appropriate baseline laboratory testing following ACEI or ARB initiation by Medicare FFS beneficiaries.Pharmacoepidemiol Drug Saf, vol. 25, no. 9, Sept. 2016, pp. 1015–22. Pubmed, doi:10.1002/pds.3994.
Maciejewski ML, Hammill BG, Qualls LG, Hastings SN, Wang V, Curtis LH. Appropriate baseline laboratory testing following ACEI or ARB initiation by Medicare FFS beneficiaries. Pharmacoepidemiol Drug Saf. 2016 Sep;25(9):1015–1022.

Published In

Pharmacoepidemiol Drug Saf

DOI

EISSN

1099-1557

Publication Date

September 2016

Volume

25

Issue

9

Start / End Page

1015 / 1022

Location

England

Related Subject Headings

  • White People
  • United States
  • Retrospective Studies
  • Potassium
  • Pharmacology & Pharmacy
  • Medicare
  • Male
  • Logistic Models
  • Hypertension
  • Humans